Pinnacle Wealth Planning Services’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$189K Buy
1,030
+10
+1% +$1.84K 0.02% 500
2025
Q4
$180K Buy
+1,020
New +$167K 0.02% 503
2023
Q3
Sell
-771
Closed -$220K 455
2023
Q2
$220K Buy
771
+3
+0.4% +$893 0.04% 354
2023
Q1
$214K Sell
768
-81
-10% -$22.4K 0.04% 370
2022
Q4
$235K Buy
+849
New +$240K 0.04% 319
2021
Q4
Sell
-711
Closed -$201K 433
2021
Q3
$201K Buy
711
+3
+0.4% +$983 0.04% 331
2021
Q2
$245K Sell
708
-7
-1% -$2.12K 0.06% 277
2021
Q1
$200K Buy
715
+256
+56% +$69K 0.05% 306
2020
Q4
$113K Buy
+459
New +$118K 0.03% 422
2020
Q2
Sell
-655
Closed -$206K 273
2020
Q1
$206K Buy
+655
New +$199K 0.1% 187
2019
Q1
Sell
-1,231
Closed -$370K 168
2018
Q4
$370K Buy
1,231
+5
+0.4% +$1.6K 0.24% 81
2018
Q3
$434K Sell
1,226
-65
-5% -$22.4K 0.4% 86
2018
Q2
$375K Buy
1,291
+18
+1% +$5.06K 0.36% 92
2018
Q1
$348K Buy
1,273
+857
+206% +$266K 0.36% 99
2017
Q4
$133K Buy
+416
New +$133K 0.27% 72

Other funds holding BIIB

Pinnacle Wealth Planning Services's BIIB Position: Q1 2026 in Review

Pinnacle Wealth Planning Services increased its Biogen (BIIB) stake by 0.98% in Q1 2026, buying an estimated $1.84K and bringing the position to 1,030 shares worth $189K. The position accounts for 0.02% of the portfolio, ranked #500.

Pinnacle Wealth Planning Services first reported a position in BIIB in Q4 2017 and has held it in 15 quarters since. The position peaked at $434K in Q3 2018. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Pinnacle Wealth Planning Services held 1,030 shares of Biogen worth $189K as of Q1 2026.
  • Pinnacle Wealth Planning Services bought 10 Biogen shares in Q1 2026, an estimated $1.84K.
  • Biogen made up 0.02% of Pinnacle Wealth Planning Services's portfolio in Q1 2026, its #500 holding.
  • Pinnacle Wealth Planning Services first reported a position in Biogen in Q4 2017 and has held it in 15 quarters since.
  • Pinnacle Wealth Planning Services's Biogen position peaked at $434K in Q3 2018.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q1 2026, filed 11 May 2026.